Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,318
Sort by:
Italy HIV/AIDS Diagnostics Market Shares and Segment Forecasts, 2019-2023: HIV 1/2, Combo, Ag, NAT, Western Blot
US$ 900.00
... forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments: ... sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Bio-Rad, DiaSorin, Grifols, Ortho Clinical Diagnostics/J&J, Roche, ...
March 2019
60 pages
Japan HIV/AIDS Diagnostics Market Shares and Segment Forecasts, 2019-2023: HIV 1/2, Combo, Ag, NAT, Western Blot
US$ 900.00
... forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments: ... provides sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Fujirebio, Grifols, Ortho Clinical Diagnostics/J&J, Roche, ...
March 2019
60 pages
2019-2023 Latin America Diagnostics Market: Sales Forecasts for 400 Blood Banking, Cancer Diagnostic, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, and TDM Tests
US$ 17,500.00
... report from LeadingMarketResearch.com provides granular analysis of the Latin America diagnostic testing market, including Argentina, Brazil, Chile, Colombia, Mexico, ... forecasts by test for the following market segments: Blood Banking Cancer Diagnostics Chemistry Coagulation Drugs of Abuse Endocrine ...
March 2019
260 pages
2019-2023 Middle East Diagnostics Market: Sales Forecasts for 500 Blood Banking, Cancer Diagnostic, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, and TDM Tests
US$ 24,500.00
... report from LeadingMarketResearch.com provides granular analysis of the Middle East diagnostic testing market, including Bahrain, Iran, Iraq, Israel, Jordan, Kuwait ... sales forecasts by test for the following market segments: Blood Banking Cancer Diagnostics Chemistry Coagulation Drugs of Abuse Endocrine ...
March 2019
410 pages
Spain HIV/AIDS Diagnostics Market Shares and Segment Forecasts, 2019-2023: HIV 1/2, Combo, Ag, NAT, Western Blot
US$ 900.00
... forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments: ... and market share estimates for major suppliers of AIDS tests, including Abbott, Biokit, bioMerieux, Bio-Rad, Fujirebio, Grifols, Ortho-Clinical Diagnostics/J&J, Roche ...
March 2019
60 pages
UK HIV/AIDS Diagnostics Market Shares and Segment Forecasts, 2019-2023: HIV 1/2, Combo, Ag, NAT, Western Blot
US$ 900.00
... forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments: Hospitals ... sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Bio-Rad, Grifols, Ortho Clinical Diagnostics/J&J, Roche, ...
March 2019
60 pages
UK Immunodiagnostics Market Shares and Sales Segment Forecasts by Test, 2019-2023
US$ 850.00
This report provides an overview of the U.K. immunodiagnostics market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays. Contains 25 pages and 5 tables
March 2019
25 pages
US HIV/AIDS Diagnostics Market Shares and Segment Forecasts: HIV 1/2, Combo, Ag, NAT, Western Blot
US$ 900.00
... forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments: Hospitals ... sales and market Share estimates for major suppliers of AIDS testing including Abbott, bioMerieux, Bio-Rad, Grifols, Ortho Clinical Diagnostics, and Roche ...
March 2019
60 pages
US Immunodiagnostics Market Shares and Sales Segment Forecasts by Test, 2019-2023
US$ 950.00
This report provides an overview of the US immunodiagnostics market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays. Contains 35 pages and 5 tables
March 2019
35 pages
